A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial

Detalles Bibliográficos
Autores principales: Burnett, A K, Hills, R K, Nielsen, O J, Freeman, S, Ali, A, Cahalin, P, Hunter, A, Thomas, I F, Russell, N H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286330/
https://www.ncbi.nlm.nih.gov/pubmed/29875430
http://dx.doi.org/10.1038/s41375-018-0148-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286330/
https://www.ncbi.nlm.nih.gov/pubmed/29875430
http://dx.doi.org/10.1038/s41375-018-0148-3

Ejemplares similares